Evidence map›Paper›PMID 27919034›Full record

ArticleBioscience reports2014

Analysis of the minimal specificity of caspase-2 and identification of Ac-VDTTD-AFC as a caspase-2-selective peptide substrate.

Tanja Kitevska, Sarah J Roberts, Delara Pantaki-Eimany, Sarah E Boyd, Fiona L Scott, Christine J Hawkins

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Caspases and their substrates.Cell death and differentiation · 2017
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tanja KitevskaDepartment of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora 3086, Victoria, Australia.
Sarah J RobertsDepartment of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora 3086, Victoria, Australia.
Delara Pantaki-EimanyDepartment of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora 3086, Victoria, Australia.
Sarah E BoydDepartment of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora 3086, Victoria, Australia.
Fiona L ScottReceptos, 10835 Road to the Cure, Suite 205, San Diego, CA 92121, U.S.A.
Christine J HawkinsDepartment of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora 3086, Victoria, Australia c.hawkins@latrobe.edu.au.
La Trobe University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caspase-2 is an evolutionarily conserved but enigmatic protease whose biological role remains poorly understood. To date, research into the functions of caspase-2 has been hampered by an absence of reagents that can distinguish its activity from that of the downstream apoptotic caspase, caspase-3. Identification of protein substrates of caspase-2 that are efficiently cleaved within cells may also provide clues to the role of this protease. We used a yeast-based transcriptional reporter system to define the minimal substrate specificity of caspase-2. The resulting profile enabled the identification of candidate novel caspase-2 substrates. Caspase-2 cleaved one of these proteins, the cancer-associated transcription factor Runx1, although with relatively low efficiency. A fluorogenic peptide was derived from the sequence most efficiently cleaved in the context of the transcriptional reporter. This peptide, Ac-VDTTD-AFC, was efficiently cleaved by purified caspase-2 and auto-activating caspase-2 in mammalian cells, and exhibited better selectivity for caspase-2 relative to caspase-3 than reagents that are currently available. We suggest that this reagent, used in parallel with the traditional caspase-3 substrate Ac-DEVD-AFC, will enable researchers to monitor caspase-2 activity in cell lysates and may assist in the determination of stimuli that activate caspase-2 in vivo.

Indexed as

Caspase 2Caspase 3Core Binding Factor Alpha 2 SubunitCysteine EndopeptidasesEnzyme ActivationHEK293 CellsHumansPeptidesCASP2 protein, humanCASP3 protein, humanCaspase 2Caspase 3Core Binding Factor Alpha 2 SubunitCysteine EndopeptidasesPeptidesRUNX1 protein, humanapoptosiscaspasecleavageproteaseRunx1substrate

Identifiers

PMID27919034
PMCPMC3966047
OpenAlexW2320927776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.